Karuna Therapeutics

Home » Karuna Therapeutics

IPO

Karuna Therapeutics

Biopharmaceutical

We are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.

Symbol

KRTX

Price Range
$15.00 - $17.00

Final Shares
4,375,000

Anticipated Date
June 28, 2019

Underwriters
GOLDMAN SACHS & CO. LLC ,CITIGROUP GLOBAL MARKETS INC.,WELLS FARGO SECURITIES, LLC

To view the prospectus for Karuna Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253